At Brigham and Women’s Hospital's Biomedical Research Institute (BRI), more than 160 principal investigators—with more than 200 funded grants—investigate cancer-related questions. Working in proximate laboratories and at scientific retreats, BWH researchers and physicians bring their collective expertise to bear on pressing questions that may enhance our knowledge of cancer prevention, develop and implement new cancer therapies, or improve existing cancer treatments. Working side by side, investigators in the BWH-BRI Cancer Research Center are uniquely positioned to facilitate the transfer of their most promising findings to patients at BWH. More>>
Featured BWH-BRI Cancer Investigators
BWH-BRI Cancer Research Center investigators have advanced and contributed insights to the world-wide community of scientists, physicians, policy makers, and the general public. The following profiles feature some of the leaders in cancer research at BWH.
More>>
Dr. Rona Carroll's work focuses on the development of novel therapies for controlling brain tumor growth using new and improved drug delivery systems. |
Dr. Mark Johnson's research is focused on finding new and better ways to treat gliomas, a class of tumors that arise in the brain. |
Dr. Elliott Kieff's viral oncology group focuses mainly on three oncogenic viruses: EBV; Kaposi’s sarcoma-associated herpesvirus, also known as human herpesvirus 8 (HHV8); and human papillomavirus (HPV), which has been implicated in cervical cancer. |
Dr. David Kwiatkowski is an acknowledged expert on tuberous sclerosis (TS), a rare genetic disorder in which multiple tumors develop in many different organs, including brain, kidney, lung, and skin. |
